@misc{indiciaed044719e8cae,
  title = {FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.},
  author = {Chang, C.-C. and Takada, Y. K. and Cheng, C.-W. and Maekawa, Y. and Mori, S. and takada, y.},
  year = {2023},
  doi = {10.1101/2023.12.01.569657},
  url = {https://www.biorxiv.org/content/10.1101/2023.12.01.569657v1},
  note = {Source identifier: 10.1101/2023.12.01.569657}
}